title: Bivalirudin: treatment effect versus side effect.
authors.affiliation: Third Department of Cardiology, Silesian Center for Heart Disease, Medical University of Silesia, Zabrze, Poland.
authors.forename: Bartosz
authors.initials: B
authors.lastname: Hudzik
authors.forename: Jaroslaw
authors.initials: J
authors.lastname: Gorol
authors.forename: Janusz
authors.initials: J
authors.lastname: Szkodzinski
authors.forename: Andrzej
authors.initials: A
authors.lastname: Lekston
authors.forename: Lech
authors.initials: L
authors.lastname: Polonski
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy*; D000991:Antithrombins / Q000627:therapeutic use*; D005260:Female; D006629:Hirudins; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; C074619:bivalirudin